Company
Keros Therapeutics, Inc.
Keros Therapeutics, Inc. has 1 drug tracked on RxWires: 1 in Phase 2.
Pipeline
| Drug | Phase | Indication |
|---|---|---|
| KER-065 | Phase 2 | Duchenne Muscular Dystrophy |
Latest
No recent events.
Follow Keros Therapeutics, Inc. on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.